Systematic review with meta‐analysis: liver transplant provides survival benefit in patients with acute on chronic liver failure
Alimentary Pharmacology & Therapeutics2020Vol. 52(2), pp. 222–232
Citations Over TimeTop 10% of 2020 papers
Mohamed Abdallah, Muhammad Waleed, Matthew G. Bell, Morgan E. Nelson, Robert J. Wong, Vinay Sundaram, Ashwani K. Singal
Abstract
In this pooled analysis with a large sample size across the globe, LT for select patients with ACLF provided survival benefit. However, larger prospective studies are needed to further refine selection criteria, especially for ACLF-3 patients as basis for improving outcomes and optimal utilisation of scarce donor pool.
Related Papers
- → Is severe progressive liver disease caused by alpha‐1‐antitrypsin deficiency more common in children or adults?(2016)45 cited
- → Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era(2004)41 cited
- → Liver disease and anesthesia(1993)1 cited
- → Comparison between MELD and Child- Pugh Scores for liver allocation(2007)
- → Advances in the application of model for end-stage liver disease and MELD-Na scores in liver transplantation(2019)